• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

现代临床研究时代医疗器械试验设计与分析的贝叶斯方法。

Bayesian approach for design and analysis of medical device trials in the era of modern clinical studies.

作者信息

Cao Han, Yao Chen, Yuan Ying

机构信息

Department of Biostatistics, Peking University First Hospital, Beijing, China.

Medical Data Science Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.

出版信息

Med Rev (2021). 2023 Oct 3;3(5):408-424. doi: 10.1515/mr-2023-0026. eCollection 2023 Oct.

DOI:10.1515/mr-2023-0026
PMID:38283256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10810749/
Abstract

Medical device technology develops rapidly, and the life cycle of a medical device is much shorter than drugs. It is necessary to evaluate the safety and effectiveness of a medical device in a timely manner to keep up with technology flux. Bayesian methods provides an efficient approach to addressing this challenge. In this article, we review the characteristics of the Bayesian approach and some Bayesian designs that were commonly used in medical device regulatory setting, including Bayesian adaptive design, Bayesian diagnostic design, Bayesian multiregional design, and Bayesian label expansion study. We illustrate these designs with medical devices approved by the US Food and Drug Administration (FDA). We also review several innovative Bayesian information borrowing methods, and briefly discuss the challenges and future directions of the Bayesian application in medical device trials. Our objective is to promote the use of the Bayesian approach to accelerate the development of innovative medical devices and their accessibility to patients for effective disease diagnoses and treatments.

摘要

医疗设备技术发展迅速,医疗设备的生命周期比药物短得多。及时评估医疗设备的安全性和有效性以跟上技术潮流是很有必要的。贝叶斯方法为应对这一挑战提供了一种有效的途径。在本文中,我们回顾了贝叶斯方法的特点以及一些在医疗设备监管环境中常用的贝叶斯设计,包括贝叶斯适应性设计、贝叶斯诊断设计、贝叶斯多区域设计和贝叶斯标签扩展研究。我们用美国食品药品监督管理局(FDA)批准的医疗设备来说明这些设计。我们还回顾了几种创新的贝叶斯信息借用方法,并简要讨论了贝叶斯方法在医疗设备试验中的应用所面临的挑战和未来方向。我们的目标是促进贝叶斯方法的使用,以加速创新医疗设备的开发及其对患者的可及性,从而实现有效的疾病诊断和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1d6/10810749/3284bcdb4617/j_mr-2023-0026_fig_001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1d6/10810749/3284bcdb4617/j_mr-2023-0026_fig_001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1d6/10810749/3284bcdb4617/j_mr-2023-0026_fig_001.jpg

相似文献

1
Bayesian approach for design and analysis of medical device trials in the era of modern clinical studies.现代临床研究时代医疗器械试验设计与分析的贝叶斯方法。
Med Rev (2021). 2023 Oct 3;3(5):408-424. doi: 10.1515/mr-2023-0026. eCollection 2023 Oct.
2
Bayesian approaches in medical device clinical trials: a discussion with examples in the regulatory setting.医疗器械临床试验中的贝叶斯方法:在监管环境下的实例探讨
J Biopharm Stat. 2011 Sep;21(5):938-53. doi: 10.1080/10543406.2011.589650.
3
Bayesian Statistics for Medical Devices: Progress Since 2010.贝叶斯统计学在医疗器械中的应用:2010 年以来的进展。
Ther Innov Regul Sci. 2023 May;57(3):453-463. doi: 10.1007/s43441-022-00495-w. Epub 2023 Mar 3.
4
Streamlining Randomized Clinical Trials for Device Therapies in Heart Failure: Bayesian Borrowing of External Data.优化心力衰竭器械治疗的随机临床试验:外部数据的贝叶斯借用
J Am Heart Assoc. 2024 Feb 6;13(3):e033255. doi: 10.1161/JAHA.123.033255. Epub 2024 Jan 23.
5
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
6
Comparative Study of Bayesian Information Borrowing Methods in Oncology Clinical Trials.贝叶斯信息借用方法在肿瘤临床试验中的比较研究。
JCO Precis Oncol. 2022 Mar;6:e2100394. doi: 10.1200/PO.21.00394.
7
Using Bayesian statistics in confirmatory clinical trials in the regulatory setting: a tutorial review.在监管环境下的验证性临床试验中使用贝叶斯统计:教程综述。
BMC Med Res Methodol. 2024 May 7;24(1):110. doi: 10.1186/s12874-024-02235-0.
8
Artificial discs for lumbar and cervical degenerative disc disease -update: an evidence-based analysis.用于腰椎和颈椎退行性椎间盘疾病的人工椎间盘——最新进展:基于证据的分析
Ont Health Technol Assess Ser. 2006;6(10):1-98. Epub 2006 Apr 1.
9
Adaptive Bayesian information borrowing methods for finding and optimizing subgroup-specific doses.自适应贝叶斯信息借用方法,用于寻找和优化亚组特异性剂量。
Clin Trials. 2024 Jun;21(3):308-321. doi: 10.1177/17407745231212193. Epub 2024 Jan 19.
10
Critical appraisal of Bayesian dynamic borrowing from an imperfectly commensurate historical control.贝叶斯动态借用不完美匹配历史对照的批判性评价。
Pharm Stat. 2020 Sep;19(5):613-625. doi: 10.1002/pst.2018. Epub 2020 Mar 17.

引用本文的文献

1
Bayesian dynamic borrowing in group-sequential design for medical device studies.医疗器械研究成组序贯设计中的贝叶斯动态借用法
BMC Med Res Methodol. 2025 Mar 20;25(1):78. doi: 10.1186/s12874-025-02520-6.
2
Comparison of Borrowing Methods for Incorporating Historical Data in Single-Arm Phase II Clinical Trials.单臂II期临床试验中纳入历史数据的借用方法比较
Ther Innov Regul Sci. 2025 Jan;59(1):20-30. doi: 10.1007/s43441-024-00723-5. Epub 2024 Nov 21.

本文引用的文献

1
SAM: Self-adapting mixture prior to dynamically borrow information from historical data in clinical trials.SAM:在临床试验中,从历史数据中动态借用信息之前的自适应混合。
Biometrics. 2023 Dec;79(4):2857-2868. doi: 10.1111/biom.13927. Epub 2023 Sep 18.
2
On efficient posterior inference in normalized power prior Bayesian analysis.在规范化幂先验贝叶斯分析中的有效后验推断。
Biom J. 2023 Jun;65(5):e2200194. doi: 10.1002/bimj.202200194. Epub 2023 Mar 23.
3
Propensity score stratified MAP prior and posterior inference for incorporating information across multiple potentially heterogeneous data sources.
倾向评分分层 MAP 先验和后验推断,用于整合多个潜在异质数据源的信息。
J Biopharm Stat. 2024 Mar;34(2):190-204. doi: 10.1080/10543406.2023.2181354. Epub 2023 Mar 7.
4
Bayesian optimal phase II designs with dual-criterion decision making.贝叶斯最优 II 期设计与双重标准决策。
Pharm Stat. 2023 Jul-Aug;22(4):605-618. doi: 10.1002/pst.2296. Epub 2023 Mar 5.
5
Bayesian design of multi-regional clinical trials with time-to-event endpoints.贝叶斯设计的多区域临床试验与时间事件终点。
Biometrics. 2023 Dec;79(4):3586-3598. doi: 10.1111/biom.13820. Epub 2023 Jan 12.
6
Digital Health and Big Data Analytics: Implications of Real-World Evidence for Clinicians and Policymakers.数字健康与大数据分析:真实世界证据对临床医生和政策制定者的影响。
Int J Environ Res Public Health. 2022 Jul 8;19(14):8364. doi: 10.3390/ijerph19148364.
7
Comparative Study of Bayesian Information Borrowing Methods in Oncology Clinical Trials.贝叶斯信息借用方法在肿瘤临床试验中的比较研究。
JCO Precis Oncol. 2022 Mar;6:e2100394. doi: 10.1200/PO.21.00394.
8
Propensity score-integrated power prior approach for augmenting the control arm of a randomized controlled trial by incorporating multiple external data sources.倾向得分整合的幂先验方法,通过纳入多个外部数据源来增强随机对照试验的对照组。
J Biopharm Stat. 2022 Jan 2;32(1):158-169. doi: 10.1080/10543406.2021.1998098. Epub 2021 Nov 10.
9
Elastic priors to dynamically borrow information from historical data in clinical trials.弹性先验以在临床试验中动态借鉴历史数据中的信息。
Biometrics. 2023 Mar;79(1):49-60. doi: 10.1111/biom.13551. Epub 2021 Sep 20.
10
Propensity-score-based meta-analytic predictive prior for incorporating real-world and historical data.基于倾向评分的元分析预测先验,用于纳入真实世界和历史数据。
Stat Med. 2021 Sep 30;40(22):4794-4808. doi: 10.1002/sim.9095. Epub 2021 Jun 14.